The standard period for patent exclusivity is typically 20 years from the date of filing the patent application. However, various extensions and exclusivities can be granted, extending this period. For instance, the Pediatric Exclusivity Provision under the Best Pharmaceuticals for Children Act (BPCA) grants an additional six months of exclusivity if the manufacturer conducts FDA-requested pediatric studies.
